Rhiannon Lowe

Rhiannon Lowe is an experienced Principal Scientist and Toxicologist currently working at BenevolentAI, leading safety studies for the company's drug discovery and development portfolio. Prior to this role, Rhiannon has worked at GSK as an Investigator in Immunotoxicology and Preclinical Gene Therapy, and as a Senior Scientist on various projects. Lowe has also been involved in CRACK IT project Challenge 21: InMutaGene, STEM Ambassador roles, and has a strong educational background with a PhD in Virology/Immunology from Imperial College London. Rhiannon's expertise spans across various disease indications and Rhiannon has a proven track record of successful collaborations with multidisciplinary teams and outsourcing partners.